← FDA Drug Approvals (Drugs@FDA)

NETARSUDIL MESYLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND PHARMA LTD · Approved 2024-01-05

Drug application

FDA Application #

ANDA216855

Application type

Abbreviated New Drug Application (Generic)

Brand name

NETARSUDIL MESYLATE

Generic name

Netarsudil

Active ingredients

NETARSUDIL

Dosage form

SOLUTION

Route

DROPS

Marketing status

Prescription

Sponsor

GLAND PHARMA LTD

First approval

2024-01-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown